Town Plaza Optical - Medicare Optometrist in Batesville, AR

Town Plaza Optical is a medicare enrolled "Optometrist" provider in Batesville, Arkansas. Their current practice location is 1119 N Saint Louis, Batesville, Arkansas. You can reach out to their office (for appointments etc.) via phone at (870) 793-6857.

Town Plaza Optical is licensed to practice in Arkansas (license number AR2425) and it also participates in the medicare program. Town Plaza Optical is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1346377678.

Contact Information

Town Plaza Optical
1119 N Saint Louis,
Batesville, AR 72501-9458
(870) 793-6857
Not Available



Healthcare Provider's Profile

Full NameTown Plaza Optical
TypeFacility
SpecialityOptometrist
Location1119 N Saint Louis, Batesville, Arkansas
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1346377678
  • Provider Enumeration Date: 02/27/2007
  • Last Update Date: 11/12/2020
  Medicare PECOS Information:
  • PECOS PAC ID: 8325135163
  • Enrollment ID: O20071026000174

Medical Identifiers

Medical identifiers for Town Plaza Optical such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1346377678NPI-NPPES
127707722MedicaidAR
126161722MedicaidAR
48815OtherARBLUECROSSBLUESHEILD

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
152W00000XOptometrist AR2425 (Arkansas)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Town Plaza Optical acts as a billing entity for following providers:
Provider NameJames D Ladd
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1508910167
PECOS PAC ID: 4789771536
Enrollment ID: I20110404000676

News Archive

New study says surgery still the best option for prostate cancer

A study by Swedish researchers has found that men who opt to have cancerous prostates surgically removed, have higher long-term survival rates than those who delay the operation, and the benefits of surgery may be greatest for men under 65.

Researchers deploy bacteriophages to fight against antibiotic resistance

In the battle against antibiotic resistance, many scientists have been trying to deploy naturally occurring viruses called bacteriophages that can infect and kill bacteria.

New LED device may help advance photodynamic therapy for skin cancer

Can skin cancer be treated with light? Scientists at the University of California, Irvine (UC Irvine), believe so. They're exploring new ways to image cancerous lesions using LEDs that might advance a technique for treating cancer called photodynamic therapy (PDT) - work that they will describe at the Optical Society's (OSA) 94th annual meeting, Frontiers in Optics (FiO) 2010 at the Rochester Riverside Convention Center in Rochester, N.Y., from Oct. 24-28.

Combination of metformin and chemoradiation does not add survival benefit in patients with LA-NSCLC

A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001. These results were recently published in JAMA Oncology.

Introgen wins European patent decision on p53 gene therapeutic

Introgen Therapeutics has announced that it was successful in winning the decision regarding its opposition of European Patent 0 390 323 before the European Patent Office (EPO) in which all claims directed to therapeutic applications of the p53 gene, the active component of Introgen's Advexin molecular therapy, were finally revoked by the EPO's Technical Board of Appeals.

Read more Medical News

› Verified 6 days ago

Provider NameEmily L Smith
Provider TypePractitioner - Optometry
Provider IdentifiersNPI Number: 1831505460
PECOS PAC ID: 9537389440
Enrollment ID: I20140926002070

News Archive

New study says surgery still the best option for prostate cancer

A study by Swedish researchers has found that men who opt to have cancerous prostates surgically removed, have higher long-term survival rates than those who delay the operation, and the benefits of surgery may be greatest for men under 65.

Researchers deploy bacteriophages to fight against antibiotic resistance

In the battle against antibiotic resistance, many scientists have been trying to deploy naturally occurring viruses called bacteriophages that can infect and kill bacteria.

New LED device may help advance photodynamic therapy for skin cancer

Can skin cancer be treated with light? Scientists at the University of California, Irvine (UC Irvine), believe so. They're exploring new ways to image cancerous lesions using LEDs that might advance a technique for treating cancer called photodynamic therapy (PDT) - work that they will describe at the Optical Society's (OSA) 94th annual meeting, Frontiers in Optics (FiO) 2010 at the Rochester Riverside Convention Center in Rochester, N.Y., from Oct. 24-28.

Combination of metformin and chemoradiation does not add survival benefit in patients with LA-NSCLC

A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001. These results were recently published in JAMA Oncology.

Introgen wins European patent decision on p53 gene therapeutic

Introgen Therapeutics has announced that it was successful in winning the decision regarding its opposition of European Patent 0 390 323 before the European Patent Office (EPO) in which all claims directed to therapeutic applications of the p53 gene, the active component of Introgen's Advexin molecular therapy, were finally revoked by the EPO's Technical Board of Appeals.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Town Plaza Optical is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Town Plaza Optical
1119 N Saint Louis,
Batesville, AR 72501-9458

Ph: (870) 793-6857
Town Plaza Optical
1119 N Saint Louis,
Batesville, AR 72501-9458

Ph: (870) 793-6857

News Archive

New study says surgery still the best option for prostate cancer

A study by Swedish researchers has found that men who opt to have cancerous prostates surgically removed, have higher long-term survival rates than those who delay the operation, and the benefits of surgery may be greatest for men under 65.

Researchers deploy bacteriophages to fight against antibiotic resistance

In the battle against antibiotic resistance, many scientists have been trying to deploy naturally occurring viruses called bacteriophages that can infect and kill bacteria.

New LED device may help advance photodynamic therapy for skin cancer

Can skin cancer be treated with light? Scientists at the University of California, Irvine (UC Irvine), believe so. They're exploring new ways to image cancerous lesions using LEDs that might advance a technique for treating cancer called photodynamic therapy (PDT) - work that they will describe at the Optical Society's (OSA) 94th annual meeting, Frontiers in Optics (FiO) 2010 at the Rochester Riverside Convention Center in Rochester, N.Y., from Oct. 24-28.

Combination of metformin and chemoradiation does not add survival benefit in patients with LA-NSCLC

A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not found to add survival benefit in the NRG Oncology clinical trial NRG-LU001. These results were recently published in JAMA Oncology.

Introgen wins European patent decision on p53 gene therapeutic

Introgen Therapeutics has announced that it was successful in winning the decision regarding its opposition of European Patent 0 390 323 before the European Patent Office (EPO) in which all claims directed to therapeutic applications of the p53 gene, the active component of Introgen's Advexin molecular therapy, were finally revoked by the EPO's Technical Board of Appeals.

Read more News

› Verified 6 days ago


Optometrist in Batesville, AR

Hayden Sowers Optometry Pa
Optometrist
Medicare: Not Enrolled in Medicare
Practice Location: 2402 Harrison St, Batesville, AR 72501
Phone: 870-793-4681    
Dr. Dustin Vance, O.D.
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 3150 Harrison St, Batesville, AR 72501
Phone: 870-793-6544    
Eagle Mountain Eye Care
Optometrist
Medicare: Medicare Enrolled
Practice Location: 3150 Harrison St, Batesville, AR 72501
Phone: 870-793-6544    Fax: 870-793-7024
Dr. Dale Ladd, PA
Optometrist
Medicare: Accepting Medicare Assignments
Practice Location: 1119 N Saint Louis, Batesville, AR 72501
Phone: 870-793-6857    
Batesville Eye Care Center
Optometrist
Medicare: Medicare Enrolled
Practice Location: 2615 Harrison St, Batesville, AR 72501
Phone: 870-793-4400    Fax: 870-793-4000
Sam D Cooke, OD
Optometrist
Medicare: Medicare Enrolled
Practice Location: 2402 Harrison St, Batesville, AR 72501
Phone: 870-793-4681    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.